Clinical Trials Browser

Phase 1 × INDUSTRY × TVB-2640 × Clear all

NCT02223247 2017-08-14

A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors

Phase 1 Completed

Neoplasms